LinkedIn Announcement:
December 2, 2024

Pharmidex is excited to share that our Head of Oncology, Dr. Christopher Ireson, will be attending the DRUG DISCOVERY Paris: SINGLE CELL GENOMICS forum on 3 December 2024! 🎉
This event, organized by ELRIG UK (https://lnkd.in/enEA8GuS), brings together thought leaders in drug discovery and genomics, focusing on the latest advancements in single-cell technologies.

Dr. Ireson is eager to connect with fellow attendees to discuss cutting-edge research and explore potential collaborations. If you’re attending, he’d be delighted to meet with you, don’t hesitate to reach out or catch him at the event!

#Pharmidex #DrugDiscovery #SingleCellGenomics #OncologyResearch

May 8, 2025
At Pharmidex, we are proud to contribute to scientific innovation through robust and reliable bioanalytical support from early discovery to regulated studies. For over eight years, we've partnered with Shimadzu, using their LCMS-8060 and LC-2050 systems to deliver high-quality, data-driven results tailored to diverse client needs. Their instruments have played a key role in advancing our bioanalytical capabilities and supporting the success of our collaborative projects. Our Head of Operations, Ash Alavijeh , recently shared insights from our long-standing collaboration as part of Shimadzu’s 150th anniversary testimonial series. We are honored to be part of their journey and look forward to continuing this partnership built on shared values of precision, reliability, and innovation. 👉 Read more stories from the Shimadzu global community here .
May 7, 2025
At Pharmidex, we stand in solidarity with individuals and families affected by Huntington’s Disease a rare, inherited neurodegenerative condition that impacts the mind, body, and spirit. Throughout May, we reaffirm our commitment to advancing neuroscience research and supporting drug discovery efforts aimed at neurodegenerative diseases. Our team is proud to collaborate with partners working toward meaningful therapies that can improve quality of life and bring hope to the HD community. Let’s raise awareness. Let’s drive innovation. Let’s stand together.
C3 Summit London
May 5, 2025
We’re pleased to share that Mo Yaqoob from our Business Development team will be attending the C3 Summit on 8 May 2025 at 8 Northumberland Ave, London. 🔗 https://www.thec3summit.com/london-2025/  Mo is looking forward to meeting fellow attendees, exploring new partnerships, and discussing how we can work together to accelerate the development of innovative drug candidates. If you're attending, don’t hesitate to connect let’s spark the next great collaboration!
More Posts